These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 23637411)
1. Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets. Lind K; Richardson SJ; Leete P; Morgan NG; Korsgren O; Flodström-Tullberg M J Virol; 2013 Jul; 87(13):7646-54. PubMed ID: 23637411 [TBL] [Abstract][Full Text] [Related]
2. Type III interferons are expressed by Coxsackievirus-infected human primary hepatocytes and regulate hepatocyte permissiveness to infection. Lind K; Svedin E; Utorova R; Stone VM; Flodström-Tullberg M Clin Exp Immunol; 2014 Sep; 177(3):687-95. PubMed ID: 24773058 [TBL] [Abstract][Full Text] [Related]
3. Interferons induce an antiviral state in human pancreatic islet cells. Hultcrantz M; Hühn MH; Wolf M; Olsson A; Jacobson S; Williams BR; Korsgren O; Flodström-Tullberg M Virology; 2007 Oct; 367(1):92-101. PubMed ID: 17559902 [TBL] [Abstract][Full Text] [Related]
4. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. Chehadeh W; Kerr-Conte J; Pattou F; Alm G; Lefebvre J; Wattré P; Hober D J Virol; 2000 Nov; 74(21):10153-64. PubMed ID: 11024144 [TBL] [Abstract][Full Text] [Related]
5. The TLR3/IRF1/Type III IFN Axis Facilitates Antiviral Responses against Enterovirus Infections in the Intestine. Su R; Shereen MA; Zeng X; Liang Y; Li W; Ruan Z; Li Y; Liu W; Liu Y; Wu K; Luo Z; Wu J mBio; 2020 Nov; 11(6):. PubMed ID: 33203755 [TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of type I and type III interferons against porcine reproductive and respiratory syndrome virus (PRRSV). Luo R; Fang L; Jin H; Jiang Y; Wang D; Chen H; Xiao S Antiviral Res; 2011 Aug; 91(2):99-101. PubMed ID: 21569798 [TBL] [Abstract][Full Text] [Related]
7. RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. Flodström-Tullberg M; Hultcrantz M; Stotland A; Maday A; Tsai D; Fine C; Williams B; Silverman R; Sarvetnick N J Immunol; 2005 Feb; 174(3):1171-7. PubMed ID: 15661870 [TBL] [Abstract][Full Text] [Related]
8. Expression of type III interferons (IFNλs) and their receptor in Sjögren's syndrome. Apostolou E; Kapsogeorgou EK; Konsta OD; Giotakis I; Saridaki MI; Andreakos E; Tzioufas AG Clin Exp Immunol; 2016 Dec; 186(3):304-312. PubMed ID: 27613139 [TBL] [Abstract][Full Text] [Related]
9. Human interferon-lambda3 is a potent member of the type III interferon family. Dellgren C; Gad HH; Hamming OJ; Melchjorsen J; Hartmann R Genes Immun; 2009 Mar; 10(2):125-31. PubMed ID: 18987645 [TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes. Yu D; Zhao M; Dong L; Zhao L; Zou M; Sun H; Zhang M; Liu H; Zou Z Drug Des Devel Ther; 2016; 10():163-82. PubMed ID: 26792983 [TBL] [Abstract][Full Text] [Related]
11. Biological activity of interleukins-28 and -29: comparison with type I interferons. Meager A; Visvalingam K; Dilger P; Bryan D; Wadhwa M Cytokine; 2005 Jul; 31(2):109-18. PubMed ID: 15899585 [TBL] [Abstract][Full Text] [Related]
12. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2. Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG mBio; 2020 Sep; 11(5):. PubMed ID: 32913009 [TBL] [Abstract][Full Text] [Related]
13. Parainfluenza Virus 3 Blocks Antiviral Mediators Downstream of the Interferon Lambda Receptor by Modulating Stat1 Phosphorylation. Eberle KC; McGill JL; Reinhardt TA; Sacco RE J Virol; 2015 Dec; 90(6):2948-58. PubMed ID: 26719274 [TBL] [Abstract][Full Text] [Related]
14. An IFIH1 gene polymorphism associated with risk for autoimmunity regulates canonical antiviral defence pathways in Coxsackievirus infected human pancreatic islets. Domsgen E; Lind K; Kong L; Hühn MH; Rasool O; van Kuppeveld F; Korsgren O; Lahesmaa R; Flodström-Tullberg M Sci Rep; 2016 Dec; 6():39378. PubMed ID: 28000722 [TBL] [Abstract][Full Text] [Related]
15. Novel type III interferons produce anti-tumor effects through multiple functions. Li Q; Kawamura K; Tada Y; Shimada H; Hiroshima K; Tagawa M Front Biosci (Landmark Ed); 2013 Jun; 18(3):909-18. PubMed ID: 23747856 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells. Santer DM; Minty GES; Golec DP; Lu J; May J; Namdar A; Shah J; Elahi S; Proud D; Joyce M; Tyrrell DL; Houghton M PLoS Pathog; 2020 Apr; 16(4):e1008515. PubMed ID: 32353085 [TBL] [Abstract][Full Text] [Related]
17. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. Ank N; West H; Bartholdy C; Eriksson K; Thomsen AR; Paludan SR J Virol; 2006 May; 80(9):4501-9. PubMed ID: 16611910 [TBL] [Abstract][Full Text] [Related]
18. Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses. Li M; Liu X; Zhou Y; Su SB J Leukoc Biol; 2009 Jul; 86(1):23-32. PubMed ID: 19304895 [TBL] [Abstract][Full Text] [Related]
19. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817 [TBL] [Abstract][Full Text] [Related]
20. Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection. Stoltz M; Klingström J J Virol; 2010 Sep; 84(18):9140-8. PubMed ID: 20592090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]